Bolt Biotherapeutics, Inc.
- BOLT
- NASDAQ
- Biotechnology
- Immuno-Oncology
- Cancer Biotech
$4.00
Today −5.72%Quote Oct 16, 2026, 08:00 PM UTC
+19.40%over the last month
Max drawdown −7.2%From 1-month high −6.8%3 months −10.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$7.7M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$4.00
+0.0% from here
Floor
$3.96
0.9% below price
Where the price sits
8 analysts
Analyst range, low to high
$1.00$7.00
- Price $4.00
- Resistance $4.55
- Consensus $4.00
The price is just above its floor. Analysts' average target sits about 0% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BOLTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q3 2014 revenue $23.8M
- Consolidated$11.9M50.0%
- Underwater Robotic Vehicles$5.5M23.0%
- Seismic Energy Sources$3.7M15.4%
- Underwater Cables and Connectors$2.5M10.3%
- Seismic Energy Source Controllers$313,0001.3%
Industry
Biotechnology
Employees
23
Founded
2015